Furthermore, an increased level of CXCL5 chemokines not only promotes metastasis but is also related to worse prognosis (133), while CXCR2 inhibitors regress pancreatic tumor development in mice model (133). This evidence concerns the gene CXCR2 and pancreatic neoplasm.